Transcription of NCCN Clinical Practice Guidelines in Oncology NCCN ...
{{id}} {{{paragraph}}}
Example: air traffic controller
NCCN Clinical Practice Guidelines in Oncology NCCN ...
, 01/18/19 2019 National Comprehensive cancer Network (NCCN ), All rights reserved. NCCN Guidelines and this illustration may not be reproduced in any form without the express written permission of Clinical Practice Guidelines in Oncology (NCCN Guidelines )Genetic/Familial High-Risk Assessment: breast and OvarianVersion January 18, 2019 ContinueContinueNCCN Guidelines Panel Disclosures Medical Oncology cancer /Medical genetics Internal medicine Hematology/Hematology Oncology Gynecologic Oncology /Gynecology breast surgical Oncology & Public health and preventive medicine Patient advocacy*Discussion Writing Committee Member*Mary B.
Breast cancer risk and management was revised from, "No increased risk of BC" to "Unknown or insufficient evidence." GENE-5 • References b, c, and d were added. BRCA-A 1 of 2 • BRCA Pathogenic/Likely Pathogenic Variant-Positive Management for Women
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: